Trillium Therapeutics Inc. logo

Trillium Therapeutics Inc. TRIL

$ 18.44 0.0%

Country

canadaCanada

IPO year

-

Industry

Biotechnology

Stock Exchange

NASDAQ CAPITAL

CEO

Dr. Jan Skvarka

Employees in the company

29

Shares

83.8 M

Market Cap[1]

$ 1.94 B

EBITDA (LTM)

$ 3.56 M

P/E (LTM)

-

P/S (LTM)

-

EPS (LTM)

-

Other stocks of industry "Biotechnology"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.